GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Treasury Stock

Nortem Biogroup (XPAR:MLBIO) Treasury Stock : €0.00 Mil (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Nortem Biogroup's treasury stock for the quarter that ended in Dec. 2022 was €0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Nortem Biogroup Treasury Stock Historical Data

The historical data trend for Nortem Biogroup's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Treasury Stock Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Treasury Stock
- -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Treasury Stock - -

Nortem Biogroup Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines